[go: up one dir, main page]

NO980333D0 - (R)-5-brom-N-(1-etyl-4-metylheksahydro-1H-1,4-diazepin-6-yl)-2-metoksy-6-metylamino-3-pyridinkarboksamid, fremgangsmåte ved fremstilling derav og farmasöytisk sammensetning inneholdende forbindelsen - Google Patents

(R)-5-brom-N-(1-etyl-4-metylheksahydro-1H-1,4-diazepin-6-yl)-2-metoksy-6-metylamino-3-pyridinkarboksamid, fremgangsmåte ved fremstilling derav og farmasöytisk sammensetning inneholdende forbindelsen

Info

Publication number
NO980333D0
NO980333D0 NO980333A NO980333A NO980333D0 NO 980333 D0 NO980333 D0 NO 980333D0 NO 980333 A NO980333 A NO 980333A NO 980333 A NO980333 A NO 980333A NO 980333 D0 NO980333 D0 NO 980333D0
Authority
NO
Norway
Prior art keywords
compound
methylhexahydro
pyridinecarboxamide
diazepin
methylamino
Prior art date
Application number
NO980333A
Other languages
English (en)
Other versions
NO312964B1 (no
NO980333L (no
Inventor
Shiro Kato
Yoshimi Hirokawa
Toshiya Morie
Hiroshi Harada
Naoyuki Yoshida
Original Assignee
Dainippon Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co filed Critical Dainippon Pharmaceutical Co
Publication of NO980333D0 publication Critical patent/NO980333D0/no
Publication of NO980333L publication Critical patent/NO980333L/no
Publication of NO312964B1 publication Critical patent/NO312964B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/08Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO19980333A 1995-07-28 1998-01-26 (R)-5-brom-N-(1-etyl-4-metylheksahydro-1H-1,4-diazepin-6-yl)- 2-metoksy-6-metylamino-3-pyridinkarboksamid, fremgangsmåte vedfremstilling derav og farmasöytisk sammensetning inneholdendeforbindelsen, samt anvendelse av denne NO312964B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP07212495 1995-07-28
PCT/JP1996/002053 WO1997005129A1 (en) 1995-07-28 1996-07-23 (r)-5-bromo-n-(1-ethyl-4-methylhexahydro-1h-1,4-diazepin-6-yl)-2-methoxy-6-methylamino-3-pyridine-carboxamide, process for producing the same and medicinal composition containing the same

Publications (3)

Publication Number Publication Date
NO980333D0 true NO980333D0 (no) 1998-01-26
NO980333L NO980333L (no) 1998-03-23
NO312964B1 NO312964B1 (no) 2002-07-22

Family

ID=16623612

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19980333A NO312964B1 (no) 1995-07-28 1998-01-26 (R)-5-brom-N-(1-etyl-4-metylheksahydro-1H-1,4-diazepin-6-yl)- 2-metoksy-6-metylamino-3-pyridinkarboksamid, fremgangsmåte vedfremstilling derav og farmasöytisk sammensetning inneholdendeforbindelsen, samt anvendelse av denne

Country Status (24)

Country Link
US (1) US5945415A (no)
EP (1) EP0855397B1 (no)
KR (1) KR19990028395A (no)
CN (1) CN1096459C (no)
AT (1) ATE201021T1 (no)
AU (1) AU700635B2 (no)
BR (1) BR9609691A (no)
CA (1) CA2228056A1 (no)
CZ (1) CZ290442B6 (no)
DE (1) DE69612753T2 (no)
DK (1) DK0855397T3 (no)
ES (1) ES2156616T3 (no)
GR (1) GR3036089T3 (no)
HU (1) HUP9901208A3 (no)
IL (1) IL122753A (no)
MX (1) MX9800620A (no)
NO (1) NO312964B1 (no)
NZ (1) NZ312799A (no)
PL (1) PL184073B1 (no)
PT (1) PT855397E (no)
RU (1) RU2156248C2 (no)
SK (1) SK282044B6 (no)
TR (1) TR199800165T1 (no)
WO (1) WO1997005129A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19650778C2 (de) * 1996-12-06 2001-01-04 Asta Medica Ag Verwendung von Dopaminrezeptor-Antagonisten in der palliativen Tumortherapie
AU776053B2 (en) * 2000-03-31 2004-08-26 Astellas Pharma Inc. Diazepan derivatives or salts thereof
US20040048874A1 (en) * 2001-05-22 2004-03-11 Bardsley Hazel Judith New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
GB0216027D0 (en) * 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
ITBO20020198A1 (it) * 2002-04-12 2003-10-13 Univ Bologna Derivati 2 , 5 bis diammino 1 , 4 benzochenionici utili per il trattamento della malattia di alzheimer , metodo per la loro preparazione ed
BRPI0406749A (pt) * 2003-01-13 2005-12-20 Dynogen Pharmaceuticals Inc Métodos relacionados ao tratamento de distúrbios fincionais do intestino e composição farmacêutica
AU2004204827B2 (en) * 2003-01-13 2006-06-29 Dynogen Pharmaceuticals, Inc. Method of treating nausea, vomiting, retching or any combination thereof
JP2006522144A (ja) * 2003-04-04 2006-09-28 ダイノゲン ファーマシューティカルズ,インコーポレイテッド 下部尿路障害の治療方法
WO2006105117A2 (en) * 2005-03-28 2006-10-05 Dynogen Pharmaceuticals, Inc. Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors
AU2010231439A1 (en) 2009-03-31 2011-10-27 Zeria Pharmaceutical Co., Ltd. Method for manufacturing 1,5-benzodiazepine derivative
EP2818463A1 (en) 2010-08-26 2014-12-31 Kowa Co., Ltd. Production method of 1,4-diazepane derivatives
RU2438669C1 (ru) * 2010-10-29 2012-01-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" Средство, проявляющее свойства антагониста серотониновых 5-ht3-рецепторов
WO2015114608A1 (en) * 2014-02-03 2015-08-06 Mylan Laboratories Ltd Processes for the preparation of intermediates of raltegravir

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ230068A (en) * 1988-07-29 1991-07-26 Dainippon Pharmaceutical Co Indazole-3-carboxylic acid esters and amides of diaza compounds having 6,7, or 8 ring members: preparatory processes and pharmaceutical compositions
US5166341A (en) * 1988-07-29 1992-11-24 Dainippon Pharmaceutical Co., Ltd. 6-amino-1,4-hexahydro-1H-diazepine derivatives
JPH03223265A (ja) * 1990-01-26 1991-10-02 Dainippon Pharmaceut Co Ltd 環状ジアミン誘導体
JPH04210970A (ja) * 1990-01-26 1992-08-03 Dainippon Pharmaceut Co Ltd ベンズアミド誘導体及びその中間体
SU1825501A3 (ru) * 1990-10-29 1995-12-10 И.В. Комиссаров Dl-3-[(4-[4- (2-пиридил)-1- пиперазинил]бутил)] -1,8,8-триметил -3-азабицикло[3,2,1] октан-2,4-диона дигидрохлорид, проявляющий противотревожную, нейролептическую и противорвотную активность
PT100990A (pt) * 1991-10-24 1994-01-31 Smithkline Beecham Plc Derivados de piridina e sua utilizacao como substancia terapeutica

Also Published As

Publication number Publication date
PL324749A1 (en) 1998-06-08
NZ312799A (en) 1999-04-29
CA2228056A1 (en) 1997-02-13
CN1096459C (zh) 2002-12-18
MX9800620A (es) 1998-04-30
BR9609691A (pt) 1999-03-23
PL184073B1 (pl) 2002-08-30
HUP9901208A2 (hu) 2000-04-28
HK1018049A1 (en) 1999-12-10
NO312964B1 (no) 2002-07-22
SK282044B6 (sk) 2001-10-08
WO1997005129A1 (en) 1997-02-13
AU6471796A (en) 1997-02-26
US5945415A (en) 1999-08-31
SK9398A3 (en) 1998-08-05
IL122753A0 (en) 1998-08-16
CZ23098A3 (cs) 1998-06-17
KR19990028395A (ko) 1999-04-15
DE69612753D1 (de) 2001-06-13
EP0855397A1 (en) 1998-07-29
TR199800165T1 (xx) 1998-06-22
GR3036089T3 (en) 2001-09-28
HUP9901208A3 (en) 2002-10-28
ATE201021T1 (de) 2001-05-15
DE69612753T2 (de) 2005-07-07
ES2156616T3 (es) 2001-07-01
CN1192213A (zh) 1998-09-02
PT855397E (pt) 2001-08-30
DK0855397T3 (da) 2001-06-25
NO980333L (no) 1998-03-23
EP0855397B1 (en) 2001-05-09
CZ290442B6 (cs) 2002-07-17
IL122753A (en) 2000-10-31
AU700635B2 (en) 1999-01-07
EP0855397A4 (en) 1998-12-02
RU2156248C2 (ru) 2000-09-20

Similar Documents

Publication Publication Date Title
NO20020968L (no) Glukopyranosyloksypyrazolderivater, medisinske sammensetninger inneholdende det samme og intermediater forfremstillingen derav
CA2434277A1 (en) Substituted alkylamine derivatives and methods of use
AUPR213700A0 (en) Antiviral agents
DE60239939D1 (de) Neue pyrrole mit hypolipidämischer und hypocholesterischer aktivität, herstellungsverfahren, diese enthaltende pharmazeutische zusammensetzungen und deren medizinische verwendung
PT1259489E (pt) Compostos azapoliciclicos condensados con arilo.
EE200300403A (et) N-asendatud mittearomaatne heterotsükliline ühend, seda sisaldav ravimkompositsioon ning ühendi kasutamine ravimina
SE9903544D0 (sv) Novel compounds
NO20085078L (no) Nye forbindelser
WO2004026306A3 (en) Pyrazole derivatives as transforming growth factor (tgf) inhibitors
NO980333D0 (no) (R)-5-brom-N-(1-etyl-4-metylheksahydro-1H-1,4-diazepin-6-yl)-2-metoksy-6-metylamino-3-pyridinkarboksamid, fremgangsmåte ved fremstilling derav og farmasöytisk sammensetning inneholdende forbindelsen
ATE318266T1 (de) 3-substituierte chinolin-4- carbonsäureamidderivate als nk-3- und nk-2- rezeptorantagonisten
ES2051834T3 (es) El uso de tetrahidrobenzeno(c,d)indol-6 carboxamidas para la preparacion de un medicamento para el tratamiento de la ansiedad.
CA2314154A1 (en) Azepine or larger medium ring derivatives and their use as pharmaceuticals
DK0902018T3 (da) 2-(arylpheny)amino-imidazolinderivater
AU9233101A (en) 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation
NO910904D0 (no) Fremgangsmaate for fremstilling av en substituert aminforbindelse.
NO20015666L (no) Umiddelbar frigivelses medisinske sammensetninger for oral anvendelse
NO20042881L (no) Substituerte cykloheksan-derivater
MXPA04002784A (es) Sales farmaceuticamente aceptables de 20(s)-camptotecinas.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees